Compare BEEP & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEEP | KRMD |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.5M | 189.3M |
| IPO Year | 2021 | 2019 |
| Metric | BEEP | KRMD |
|---|---|---|
| Price | $2.01 | $3.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $6.50 | $6.50 |
| AVG Volume (30 Days) | 32.2K | ★ 120.4K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | $35,075,000.00 | ★ $41,127,366.00 |
| Revenue This Year | $5.77 | $20.32 |
| Revenue Next Year | $22.12 | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $1.76 | $2.63 |
| 52 Week High | $4.67 | $6.61 |
| Indicator | BEEP | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.01 | 43.56 |
| Support Level | N/A | $3.88 |
| Resistance Level | $3.24 | $4.34 |
| Average True Range (ATR) | 0.17 | 0.18 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 33.65 | 13.64 |
Mobile Infrastructure Corp focus on acquiring, owning and optimizing parking facilities and related infrastructure, including parking lots, parking garages, and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provides access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.